Protillion Biosciences Raises $18 Million Series A Financing Led by ARCH Venture Partners and Illumina Ventures

Protillion's transformational drug discovery and optimization platform generates precise protein data with the scale to bridge advanced computation and real-world results Platform can identify and optimize new protein therapeutics to accelerate R&D productivity BURLINGAME, Calif., Dec....

Click to view original post